Cargando…
Isolation of Functional SARS-CoV-2 Antigen-Specific T-Cells with Specific Viral Cytotoxic Activity for Adoptive Therapy of COVID-19
In order to demonstrate the feasibility of preparing clinical-grade SARS-CoV-2-specific T-cells from convalescent donors and the ability of these cells to neutralize the virus in vitro, we used blood collected from two COVID-19 convalescent donors (before and after vaccination) that was stimulated w...
Autores principales: | García-Ríos, Estéfani, Leivas, Alejandra, Mancebo, Francisco J., Sánchez-Vega, Laura, Lanzarot, Diego, Aguado, José María, Martínez-López, Joaquín, Paciello, María Liz, Pérez-Romero, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944951/ https://www.ncbi.nlm.nih.gov/pubmed/35327433 http://dx.doi.org/10.3390/biomedicines10030630 |
Ejemplares similares
-
Is It Feasible to Use CMV-Specific T-Cell Adoptive Transfer as Treatment Against Infection in SOT Recipients?
por: García-Ríos, Estéfani, et al.
Publicado: (2021) -
Optimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive Immunotherapy
por: Fernández, Adrián, et al.
Publicado: (2021) -
Deciphering the Potential Coding of Human Cytomegalovirus: New Predicted Transmembrane Proteome
por: Mancebo, Francisco J., et al.
Publicado: (2022) -
An outlook on antigen-specific adoptive immunotherapy for viral infections with a focus on COVID-19
por: Monzavi, Seyed Mostafa, et al.
Publicado: (2021) -
GMP-Compliant Manufacturing of NKG2D CAR Memory T Cells Using CliniMACS Prodigy
por: Fernández, Lucía, et al.
Publicado: (2019)